ROCKVILLE, MD, June 24, 2010 – Emergent BioSolutions Inc. (NYSE:EBS) led by CEO Fuad El-Hibri,announced today that it has completed separate international sales and deliveries of BioThrax® (Anthrax Vaccine Adsorbed) to governments of several allied nations. The company’s international sales efforts have resulted in these sales [...]
-
‹ Home
-
Categories
- Abdul Aziz Said
- Anthrax vaccines
- Arab
- Atlanta
- BacilleCalmette-Guerin
- BARDA
- BioDefense
- Biothrax
- Board of directors
- Business
- Businessweek
- Centers for Disease Control and Prevention
- Chief Executive Officer
- Chief financial officer
- Chief Medical Officer
- Clinical trial
- colleagues
- Dr. Mary Elizabeth King
- El-Hibri
- El-Hibri Peace Education Prize
- Emergent Bioslutions
- entrepreneur
- Federal government of the United States
- Financial Performance
- Financial Results
- Food and Drug Administration
- Foundation
- Fuad
- Fuad El-Hibri
- Healthcare
- Healthcare Conference
- Hematology
- Hudson Institute
- Infectious disease
- Investors
- Lebanon
- Leukemia
- Leukemia & Lymphoma Society
- National Health Museum
- North Atlantic Treaty Organization
- Peace Education
- Rene Moawad Foundation
- Research and development
- Resource Center
- Revenue
- Scholars Program
- Seattle
- Shareholder
- Social Network
- South Africa
- Strategic National Stockpile
- TB Vaccine
- Tech Council of Maryland
- Trubion Pharmaceuticals
- U.S. Food and Drug Administration
- Uncategorized
- United States
- Washington
- Washington D.C
- Yale university
-
Tags
Anthrax Anthrax vaccines Biomedical Advanced Research and Development Authority Biotechnology and Pharmaceuticals Biothrax Board of directors Business Centers for Disease Control and Prevention Chief executive officer Chief financial officer Clinical trial Education El-Hibri Peace Education Prize Emergent BioSolutions Emergent Biosolutions Inc Federal government of the United States Food and Drug Administration Fuad El-Hibri Health Health care Humanitarian aid Infectious disease Lebanon Maryland Middle East National Institute of Allergy and Infectious Diseases National Institutes of Health NATO Non-profit organization Peace Pharmaceuticals Private Securities Litigation Reform Act Research and development Stanford University Strategic National Stockpile Tuberculosis United States United States Department of Defense United States Department of Health and Human Services US Food and Drug Administration US government Vaccination Washington Webcast Yale university
-
Archives
- April 2012
- March 2012
- February 2012
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- January 2010
- December 2009
- October 2009
- August 2009
- July 2009
- June 2009
Blogroll
-
RSS Feeds
-
Meta